Heterozygous somatic mutations in IDH1/2 have been identified in numerous cancers [2, 3], strikingly at high frequency in glioblastoma multiforme [4] and acute myeloid leukemia (AML) [5–7]. The gene discussed is IDH1; the disease is acute myeloid leukemia.